Display Settings:

Format

Send to:

Choose Destination

    Toxicol Lett. 2004 Mar 14;148(1-2):41-51.

    The role of mdr2 in manganese-bilirubin induced cholestasis in mice.

    Akoume MY, Tuchweber B, Plaa GL, Yousef IM.

    Département de Pharmacologie, Faculté de Médecine, Université de Montréal, Centre-ville, Que., Canada.

    The pathogenesis of manganese-bilirubin (Mn-BR) induced cholestasis has only been studied in rats and is associated with alteration in the hepatic homeostasis of cholesterol and phospholipids. Multidrug resistance-2 (mdr2) transporter, which mediates excretion of these lipids, is suggested to be involved in this phenomenon. The present study was undertaken to examine if Mn-BR induced cholestasis is reproducible in mice, then to clarify the role of mdr2 in its pathogenesis, using mice with disrupted mdr2 gene (mdr2 (-/-)). Results showed that Mn-BR combination decreased bile flow in mice. This reduction in bile flow was similar in mdr2 (-/-) and the wild type mdr2 (+/+). Furthermore, the change in biliary lipid excretion was comparable in both genotypes. These data indicate that Mn-BR induced cholestasis is reproducible in mice and provide evidence that mdr2 alteration is not a primary event in this form of cholestasis.

    PMID: 15019087 [PubMed - indexed for MEDLINE]

    Supplemental Content

    Click here to read Click here to read